Literature DB >> 28914378

The spectrum of psoriatic arthritis in a South African cohort.

Jean-Paul Muzemb Kanyik1, Annibale Coi2, Asgar Ali Kalla3.   

Abstract

The aim of this study was to describe the clinical features of patients with psoriatic arthritis (PsA) in a South African cohort. This is a retrospective analysis of patients contributing to development of the international classification criteria for PsA, ClASsification criteria for Psoriatic ARthritis (CASPAR). Patients were all seen at the arthritis clinics at Groote Schuur Hospital, Cape Town. Demographic, clinical, laboratory and radiographic information was collected. This study describes the relevant findings relating to the clinical profile of the patients seen at our centre as well as the effect of family history and/or dactylitis in determining the severity of psoriatic arthritis. There were 45 patients with a male to female ratio of 1:1.25. The mean age of psoriasis onset was 38.34 years (SD 15.54), whilst that of arthritis onset was 43.86 years (SD 13.4). Polyarthritis was the commonest pattern and sacro-iliitis was uncommon. Dactylitis was present in 26%. The presence of family history or of dactylitis did not predict more severe disease. There was a significant correlation between tender and swollen joints. The mean Health Assessment Questionnaire (HAQ) score was 1.05. Eighty-three percent showed evidence of radiological changes, and distal interphalangeal (DIP) erosions were found in 54%. Arthritis mutilans was present in 31%. There were no black subjects in the cohort. The clinical patterns of PsA in our cohort are similar to those reported elsewhere. The paucity of blacks amongst this cohort requires further study. PsA-specific measures of disease activity need to be developed. PsA causes significant joint damage and disability.

Entities:  

Keywords:  Joint damage; Psoriatic arthritis; South Africa

Mesh:

Substances:

Year:  2017        PMID: 28914378     DOI: 10.1007/s10067-017-3810-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  28 in total

1.  Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation.

Authors:  L-S Tam; B Tomlinson; T T-W Chu; M Li; Y-Y Leung; L-W Kwok; T K Li; T Yu; Y-E Zhu; K-C Wong; E W-L Kun; E K Li
Journal:  Rheumatology (Oxford)       Date:  2008-04-09       Impact factor: 7.580

2.  Rheumatoid arthritis in an urban South African Negro population.

Authors:  L Solomon; G Robin; H A Valkenburg
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

3.  Prevalence and clinical patterns of psoriatic arthritis in Indian patients with psoriasis.

Authors:  Ramesh Kumar; Aman Sharma; Sunil Dogra
Journal:  Indian J Dermatol Venereol Leprol       Date:  2014 Jan-Feb       Impact factor: 2.545

Review 4.  The assessment of disease activity and outcomes in psoriatic arthritis.

Authors:  A Kavanaugh; S Cassell
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

Review 5.  Spondyloarthropathies in sub-Saharan Africa.

Authors:  M Mijiyawa; O Oniankitan; M A Khan
Journal:  Curr Opin Rheumatol       Date:  2000-07       Impact factor: 5.006

Review 6.  Psoriatic arthritis: need for ultrasound in everyday clinical practice.

Authors:  Walter Grassi; Marwin Gutierrez
Journal:  J Rheumatol Suppl       Date:  2012-07

7.  Psoriatic arthritis (PSA)--an analysis of 220 patients.

Authors:  D D Gladman; R Shuckett; M L Russell; J C Thorne; R K Schachter
Journal:  Q J Med       Date:  1987-02

8.  Psoriatic arthritis.

Authors:  Artur Jacek Sankowski; Urszula Maria Lebkowska; Jarosław Cwikła; Irena Walecka; Jerzy Walecki
Journal:  Pol J Radiol       Date:  2013-01

9.  Indices of disease activity in psoriatic arthritis.

Authors:  A O Daunt; N L Cox; J C Robertson; M I Cawley
Journal:  J R Soc Med       Date:  1987-09       Impact factor: 18.000

10.  Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression.

Authors:  Bina Menon; Nicola J Gullick; Gina J Walter; Megha Rajasekhar; Toby Garrood; Hayley G Evans; Leonie S Taams; Bruce W Kirkham
Journal:  Arthritis Rheumatol       Date:  2014-05       Impact factor: 10.995

View more
  1 in total

1.  Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country.

Authors:  Miguel A González-Gay; Patrick H Dessein; Ahmed Solomon; Anne E Stanwix; Santos Castañeda; Javier Llorca; Carlos Gonzalez-Juanatey; Bridget Hodkinson; Benitha Romela; Mahmood M T M Ally; Ajesh B Maharaj; Elsa M Van Duuren; Joyce J Ziki; Mpoti Seboka; Makgotso Mohapi; Barend J Jansen Van Rensburg; Gareth S Tarr; Kavita Makan; Charlene Balton; Aphrodite Gogakis
Journal:  BMC Rheumatol       Date:  2020-06-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.